Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. C. J. Mertens, A. Hanmandlu (ankit.hanmandlu@utexas.edu / Department of Biochemistry and Molecular Biology, M. Medical School, U. , L. Tu (Ly.Tu@inserm.fr / INSERM UMR_S 999, U. Paris-Sud,LE PLESSIS-ROBINSON), C. Phan (phan.carole@gmail.com / INSERM UMR_S 999, U. Paris-Sud,LE PLESSIS-ROBINSON), S. Collum (scott.d.collum@uth.tmc.edu / Department of Biochemistry and Molecular Biology, M. Medical School, U. , N. Chen (ning-yuan.chen@uth.tmc.edu / Department of Biochemistry and Molecular Biology, M. Medical School, U. , J. Davies (jldavies@texaschildrens.org / Department of Pediatrics, B. College of Medicine,Houston), A. Guha (gashrith@houstonmethodist.org / Debakey Heart & Vascular Center, H. Methodist Hospital,Houston), H. Eltzschig (holger.eltzschig@uth.tmc.edu / Department of Anaesthesiology, M. Medical School, U. , M. Blackburn (michael.r.blackburn@uth.tmc.edu / Department of Biochemistry and Molecular Biology, M. Medical School, U. , C. Guignabert (guignabert@gmail.com / INSERM UMR_S 999, U. Paris-Sud,Houston), H. Karmouty-Quintana (harry.karmouty@uth.tmc.edu / Department of Biochemistry and Molecular Biology, M. Medical School, U.. LSC - 2018 - Pulmonary vascular remodeling mediated by ADORA2B in pulmonary artery smooth muscle cells. 3921

Member's Comments

No comment yet.

Related content which might interest you: Role of endothelial and smooth muscle cells in vascular wall remodeling of large pulmonary arteries in patients with CTEPH Source: Annual Congress 2007 - Venous thromboembolic disease Year: 2007 Hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: possible mechanisms Source: Eur Respir J 2004; 24: Suppl. 48, 561s Year: 2004 CD163 is expressed and modulated in human pulmonary artery smooth muscle cells: Implications for pulmonary artery hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 miR 16 modulates human pulmonary artery smooth muscle cell phenotype Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Proliferative hypoxic response of pulmonary artery smooth muscle cells: the fibroblasts role Source: Eur Respir J 2007; 30: Suppl. 51, 510s Year: 2007 Mir-17 modulates smooth muscle cell markers, apoptosis and BMPR-II levels in human pulmonary artery smooth muscle cells Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Endothelin-1 downregulates BMP signaling in pulmonary artery smooth muscle cells Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments Year: 2012 SMAD3 regulation contributes to lung vascular remodeling in pulmonary arterial hypertension Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey Year: 2015 Involvement of pulmonary artery smooth muscle cell apoptosis in simvastatin-induced regression of hypoxic pulmonary hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Hypoxic pulmonary artery fibroblasts trigger proliferation of vascular smooth muscle cells - role of hypoxia-inducible transcription factors Source: Eur Respir J 2001; 18: Suppl. 33, 159s Year: 2001 Shroom expression is attenuated in pulmonary arterial hypertension Source: Eur Respir J 2008; 32: 871-880 Year: 2008 Cigarette smoke- and hypoxia-induced imbalanced vasoactive gene expression in human pulmonary artery smooth muscle cells Source: International Congress 2017 – Experimental PH Year: 2017 Pulmonary artery endothelial cell exposure to hepcidin affects BMP-signalling; relevance to vascular remodelling in PAH Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 Effect of endothelin-1 and bosentan on gene expressions in the cultured pulmonary artery smooth muscle cells Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010 Bosentan stimulates the expression of cell cycle inhibitor p27(kip1) in pulmonary artery smooth muscle cells (PASMC) Source: Annual Congress 2007 - Animal and ex vivo models of airway inflammation Year: 2007 NMDA receptor crosstalk with PDGFR-β and BMPR2 is involved in smooth muscle cell proliferation in pulmonary arterial hypertension Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Comparison of current therapies against endothelin-induced growth in pulmonary smooth arterial muscle cells (PASMCs) derived from patients with pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Vascular remodeling in chronic thromboembolic pulmonary hypertension: Involvement of dedifferentiated smooth muscle cells and C-reactive protein Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 Targeting CCR2 and CCR5 to inhibit macrophage/pulmonary artery smooth muscle cells cross-talk in pulmonary hypertension Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018